Skip to content

Cap Assisted Forward-Viewing Endoscope vs Side-Viewing Endoscope for Examination of Major Duodenal Papilla

Cap Assisted Forward-Viewing Endoscope vs Side-Viewing Endoscope for Examination of Major Duodenal Papilla

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02883608
Acronym
KappaII
Enrollment
63
Registered
2016-08-30
Start date
2016-08-31
Completion date
2017-01-22
Last updated
2017-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Duodenal Papilla, Major

Keywords

Papilla, major duodenal papilla, ampulla of vater

Brief summary

Examination of major duodenal papilla (MDP) using a standard forward-viewing esophagogastroduodenoscopy (S-EGD) is limited. Until now, side-viewing duodenoscope is the modality of choice to examine the MDP. Cap assisted esophagogastroduodenoscopy (CA-EGD) uses a cap fitted to the tip of the scope that can depress the mucosal folds and thus improve visualization and examination of MDP. The aim of this study is to compare CA-EGD to side\*viewing duodenoscope for complete examination of MDP.

Interventions

PROCEDUREcap assisted forward-viewing endoscope

a cap fitted to the to top of the forward-viewing endoscope

Sponsors

Technical University of Munich
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* indication for elective upper endoscopy * age over 18 years * ability to provide informed consent

Exclusion criteria

* surgically altered upper gastrointestinal tract * known or suspected upper gastrointestinal strictures * upper gastrointestinal bleeding * biliary stent * planned endoscopic intervention * American Society of Anesthesiologists class III or higher * contraindication for or refusal of sedation with Propofol * inability to give informed consent

Design outcomes

Primary

MeasureTime frameDescription
Rate of complete visualisation of papilla duodeni majorwithin 5 minutes after intubation of the esophaguscomplete visualization is defined by visualization of both proximal and distal ends together with the orifice of the papilla

Secondary

MeasureTime frame
Duration needed to localize the papillawithin 5 minutes after intubation of the esophagus

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026